In short
Innoviva, Inc. (INVA) has revenue up 14.7% to $411.3M and operating cash flow up 4.4% to $196.9M year on year. Its net margin is 65.9% and gross margin 74.8%, and it trades at 5.0× trailing earnings. Fisclear flags 1 medium-severity risk and no high-severity ones. How we calculate this
Valuation
HealthcareLive · Yahoo FinancePrice
$18.41
$1.3B
5.3x
52-Week Range
Decision Context
Market appears to be pricing in less growth than this company's historical average, suggesting potential upside if the trajectory continues. Quality and efficiency scores support the business case.
Based on filing period ending Sept 2026
FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.
Macro Context
Fed Funds Rate
3.88%
Accommodative
10-Year Treasury
5.13%
2026-10-01
Unemployment
4.2%
Near full employment
CPI Index
336.3
2026-09-01
M2 Money Supply
$23.4T
2026-09-01
The Federal Funds rate stands at 3.88% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 5.13%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 104.0; M2 money supply is $23.4T; CPI index stands at 336.3.
SWOT Analysis — INVA
Inflationary BoomStrengths
Net Income: $271.2M (+1059.2% YoY) — Profit grew 1059% — the company kept more of each dollar earned.
EPS (Diluted): $3.30 (+816.7% YoY) — Earnings per share rose 817% — each share earned more.
Total Assets: $1.6B (+25.7% YoY) — Total assets grew 26% — the company's resource base expanded.
Revenue: $411.3M (+14.7% YoY) — Revenue grew 15% — the company sold more goods or services than the prior year.
Weaknesses
No material weaknesses flagged.
Opportunities
Operating Cash Flow: $196.9M (+4.4% YoY) — Operating cash flow grew 4% — the business generated more cash from day-to-day operations.
Threats
Gross margin compressed by 7.8pp — input costs or pricing pressure is eroding profitability on each dollar of revenue.
Year-over-Year Changes
Net Income
$271.2M
was $23.4M
Profit grew 1059% — the company kept more of each dollar earned.
EPS (Diluted)
$3.30
was $0.36
Earnings per share rose 817% — each share earned more.
Total Assets
$1.6B
was $1.3B
Total assets grew 26% — the company's resource base expanded.
Revenue
$411.3M
was $358.7M
Revenue grew 15% — the company sold more goods or services than the prior year.
Operating Cash Flow
$196.9M
was $188.7M
Operating cash flow grew 4% — the business generated more cash from day-to-day operations.
Risk Flags
0 high · 1 medium · 0 low- ◈ Medium
Gross margin compressed by 7.8pp — input costs or pricing pressure is eroding profitability on each dollar of revenue.
Technical Signals
Daily closes · 1-year dataInnoviva, Inc.: common questions
Is Innoviva, Inc. profitable?
Yes. Innoviva, Inc. made a net profit of $271M in its latest fiscal year (fiscal 2025), a net margin of 65.9%.
Is Innoviva, Inc.'s revenue growing?
Yes. Revenue grew 14.7% year on year, to $411.3M.
What is Innoviva, Inc.'s P/E ratio?
Innoviva, Inc. trades at 7.8× its trailing twelve-month earnings. In other words, the share price is about 8 times the profit per share the company earned over the past year.
Does Innoviva, Inc. pay a dividend?
No dividend is currently expected from Innoviva, Inc., according to the latest market data.
What are the main risks for Innoviva, Inc.?
Fisclear's checks flag 1 medium- or high-severity risk. The most serious: Gross margin compressed by 7.8pp — input costs or pricing pressure is eroding profitability on each dollar of revenue.
Answers are generated from the figures in this report (updated 5 Nov 2026). Information, not investment advice.
Latest News
via FinnhubFiling History — INVA
Get the weekly digest
5 company reports + macro context every week, free. No spam.
- Unlimited goal simulations
- 5 free company report summaries per day
- Weekly financial insights newsletter
External Links
Trade INVA
Links open broker research pages. Not an endorsement or recommendation.
Research Innoviva, Inc.
Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.